版本:
中国

BRIEF-Biotime expands OpRegen clinical trial in dry-AMD with opening of first US sites

March 13 BioTime Inc-

* BioTime expands opregen® clinical trial in dry-amd with opening of first us sites

* Anticipate enrolling and treating U.S.-based patients by end of Q2 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐